Triumph Financial Announces Schedule for Second Quarter 2024 Earnings Release and Conference Call
July 05, 2024 09:05 ET
|
Triumph Financial, Inc.
DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its second quarter financial results and management commentary after the...
Provident Financial Services, Inc. Schedules Second Quarter Earnings Conference Call
July 01, 2024 08:00 ET
|
Provident Financial Services, Inc.
ISELIN, N.J., July 01, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended June 30, 2024 on Thursday,...
Beneficient Announces Fourth Quarter and Full Year Fiscal 2024 Earnings Release and Webcast
July 01, 2024 07:00 ET
|
Beneficient
Beneficient (NASDAQ: BENF) will release its Fiscal 2024 financial results on Tuesday, July 2, 2024 and will host a webcast at 8:30 a.m.
Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call
June 11, 2024 09:00 ET
|
Retail Opportunity Investments Corp.
Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
June 06, 2024 09:00 ET
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
May 29, 2024 19:21 ET
|
ALTERITY THERAPEUTICS LIMITED
- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May ...
Arbutus to Participate in Jefferies Global Healthcare Conference
May 29, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2024 INVESTOR CONFERENCE
May 28, 2024 16:07 ET
|
UMH Properties, Inc.
FREEHOLD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), today announced that the Company will participate in Nareit’s REITweek: 2024 Investor Conference, to be...
Micron Technology to Report Fiscal Third Quarter Results on June 26, 2024
May 28, 2024 16:01 ET
|
Micron Technology, Inc.
BOISE, Idaho, May 28, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal third quarter earnings conference call on Wednesday, June 26, 2024,...
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17, 2024 12:00 ET
|
Optinose, Inc.
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...